AbbVie today announced the presentation of new data across its gastroenterology portfolio at the 2026 Digestive Disease Week (DDW) Annual Meeting, May 2-5 in Chicago. AbbVie will present 18 abstracts, ...
Oruka Therapeutics’ long-acting plaque psoriasis candidate cleared the skin of 63.5% of patients in a phase 2a trial, leading Jefferies analysts to predict the asset could beat out AbbVie’s Skyrizi ...
Three years after AbbVie stood at the edge of a major patent cliff with the loss of exclusivity for immunology megablockbuster Humira, CEO Robert Michael can now declare that “we have never been in a ...
April 29 (Reuters) - AbbVie (ABBV.N), opens new tab on Wednesday reported better-than-expected quarterly revenue and profit, fueled by demand for newer immunology drugs Skyrizi and Rinvoq, as it ...
The military has influenced just about everything we wear—our closets, runway shows, and even the ability for vintage shop owners to make rent off a steady diet of rarefied, government-issued garms.
Everyday Health on MSN
Mucosal healing in Crohn's disease: What it is and why it matters
Treatment to heal the lining of the gastrointestinal tract is an increasingly common goal for inflammatory bowel disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results